retatrutide glp-1 gip glucagon receptor agonist Science Behind GLP 1 and Agonists for Obesity Research | News & Announcements LY3437943, a novel triple glucagon,
Description
Wegovy may cause serious side effects, including: inflammation of your pancreas (pancreatitis)
There are limitations in the supporting literature used for this expert consensus and further research is needed
Walters KA, Gilchrist RB, Ledger WL, et al
& Wu, X
In obesity management, GLP-1RAs in general, and semaglutide in particular, have been shown to induce significant and sustained weight loss in clinical trials (4)
Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al
